MedicWave AB (publ)

MedicWave, as a company, was founded in 2005. However, the people behind the company have been developing products related to Mass Spectrometry Bioinformatics and unique algorithms for statistics, Machine Learning and Data Mining since 2001.

Executive summary

New high throughput technologies like DNA sequencers, Micro Arrays, Mass Spectrometry and Protein Arrays have dramatically accelerated the process of collecting biological data and shifted the bottleneck in the drug discovery process from the lack of biological data to analysis of this overflow of biological data. MedicWave develops automated state-of-the-art bioinformatics/biocomputing software in order to meet post-genomic high throughput needs in the drug discovery and biotech business.

MedicWave develops state-of-the-art data analysis software for Mass Spectrometry-related Proteomics. The central importance of proteomics lies in the fact that proteins are the molecules that carry out virtually all biological processes. To understand any biological phenomenon, the role proteins play must therefore be understood. Not only are proteins axiomatic to the life of the healthy cell, but they are central to disease and its treatment too. Nearly all drug targets are proteins, and most drugs work by correcting the protein abnormalities that cause disease.

All MedicWave products are developed and used for research purposes only.